NEUROONE MEDICAL TECHNOLOGIES Corp — Director's Dealing 2021

Oct 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK: 0001500198
Period of Report: 2021-05-26

Reporting Person: Rosa David A (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-26	Option to Purchase Common Stock	$5.97	A	83333	Acquired	2031-01-27	Common Stock (83333)	Direct

Footnotes

F1: On January 27, 2021, the reporting person was granted an option to purchase shares of common stock, 83,333 shares of which were subject to performance criteria, which performance criteria were met on May 26, 2021, resulting in the vesting of that portion of the option.